The Definitive Guide to Hemgenix
Amount of qualified sufferers: CDEC reviewed the uncertainty in the volume of people with reasonably intense to intense hemophilia B in Canada suitable for etranacogene dezaparvovec. Scientific specialists consulted by CADTH indicated that some sufferers who're classified as having mild or average disorder could possibly have a significant bleeding